Amundi’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$434K Buy
+4,113
New +$364K ﹤0.01% 1602
2025
Q2
Sell
-2,058
Closed -$95.7K 2061
2025
Q1
$95.7K Buy
2,058
+25
+1% +$1.05K ﹤0.01% 1753
2024
Q4
$76.5K Hold
2,033
﹤0.01% 1816
2024
Q3
$89.4K Sell
2,033
-674
-25% -$27.2K ﹤0.01% 1789
2024
Q2
$93.4K Hold
2,707
﹤0.01% 1717
2024
Q1
$68.3K Buy
2,707
+675
+33% +$18.4K ﹤0.01% 1815
2023
Q4
$51.6K Sell
2,032
-1,687
-45% -$29.5K ﹤0.01% 1885
2023
Q3
$57.4K Hold
3,719
﹤0.01% 1850
2023
Q2
$83K Buy
+3,719
New +$93.1K ﹤0.01% 1807
2022
Q2
Sell
-3,855
Closed -$98K 1705
2022
Q1
$98K Sell
3,855
-198
-5% -$5.58K ﹤0.01% 1474
2021
Q4
$141K Buy
+4,053
New +$128K ﹤0.01% 1528

Other funds holding PTGX